CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies (FIRST-STIM)
Sponsor: Johns Hopkins University
Terminated
This trial was terminated. No reason was provided.
Listed as NCT01440452, this NA trial focuses on Inflammatory Myelopathies and remains terminated or withdrawn. Sponsored by Johns Hopkins University, it has been updated 10 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Terminated NA
-
Oct 2019 — Aug 2020 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated · Phase: PHASE2_PHASE3 → NA
-
Oct 2018 — Oct 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .